The Shield That Keeps Growing — Mississippi's COVID Immunity and the Diagnostic Delay That Can't Be Sued

A patient recovers from COVID-19 in early 2021. Weeks later, he begins losing strength in both legs. Then he can’t urinate. He goes to a hospital, then a clinic, then another provider. For three months, no one connects the dots. When the diagnosis finally arrives — transverse myelitis, a known post-COVID neurological complication — the window for optimal treatment has narrowed sharply. He and his spouse file a malpractice suit. The case never makes it past the first procedural hurdle. In Secrist v. Rush Medical Foundation, the Mississippi Supreme Court affirmed dismissal — not because the care was found adequate, but because a COVID-era immunity statute made the lawsuit legally impermissible. The court never had to evaluate the standard of care.In this episode, Bryan walks through the clinical timeline and the procedural arc of the case. Sarah unpacks Mississippi’s pandemic immunity framework — what it covers, how broadly the courts have read it, and where the outer edges of the shield actually sit for care delivered during and after the public health emergency. And Michael brings the frontline hospitalist perspective: why post-COVID transverse myelitis is so easy to miss in the first weeks of progressive weakness, the leg-weakness-plus-urinary-retention combination that should trigger emergent spine MRI on any shift, and what clinicians who practiced through 2020–2021 should understand about how immunity statutes now interact with the diagnostic decisions they made in real time.Educational purposes only. Not legal advice. Not medical advice.This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.Thanks for reading! This post is public so feel free to share it. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thecharteddefense.substack.com/subscribe